HK

Hashmatulla Khan

Active Director Director DIN 07382940
DIN 07382940 First appointment Jan 2016 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Hashmatulla Khan

Data last updated:

Hashmatulla Khan is a Director at Regenesis Meditech Private Limited (since 2016). The company operates in Chemicals. Regenesis Meditech Private Limited reported revenue of ₹1.9 Lakh (FY 2024).

DIN 07382940
Primary Designation Director
Industry Chemicals
First Appointment 19 Jan 2016
Oldest Company Age 10 yrs
Largest company Regenesis Meditech Private Limited · ₹1.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regenesis Meditech Private Limited U24100MP2016PTC035248
Director19 Jan 20162016₹1.9 Lakh (FY 2024)Active

Board colleagues of Hashmatulla Khan

NameDINCompanyDesignation
Nayab Khan07938272Regenesis Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Regenesis Meditech Private Limited
Premium access

Shareholding and investment profile for Hashmatulla Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hashmatulla Khan

Hashmatulla Khan currently holds 1 directorship: Regenesis Meditech Private Limited (Director, since 19 Jan 2016, revenue ₹1.9 Lakh (FY 2024)).

Hashmatulla Khan was first appointed on 19 Jan 2016 as Director at Regenesis Meditech Private Limited.

The current boards of Hashmatulla Khan's companies include Nayab Khan (Regenesis Meditech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available